Company · OTLC
Oncotelic Therapeutics, Inc.
OTLC is not in Nasdaq's symbol directory of securities listed on US exchanges.
In the 12 months to Nov 8, 2026: insiders bought on 9 occasions ($61K); 2 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Vuong Trieu, CHAIRMAN AND CEO bought $60K
- Amit B. Shah, CFO bought $1K
Every trade (9)
- BUYVuong Trieu, CHAIRMAN AND CEO bought $18K
- BUYVuong Trieu, CHAIRMAN AND CEO bought $6K
- BUYVuong Trieu, CHAIRMAN AND CEO bought $10K
- BUYVuong Trieu, CHAIRMAN AND CEO bought $5K
- BUYVuong Trieu, CHAIRMAN AND CEO bought $3K
- BUYVuong Trieu, CHAIRMAN AND CEO bought $3K
- BUYAmit B. Shah, CFO bought $1K
- BUYVuong Trieu, CHAIRMAN AND CEO bought $11K
- BUYVuong Trieu, CHAIRMAN AND CEO bought $4K
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Other events Oct 26, 2026
- Other events Oct 13, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.